FLUKE JOHN M JR 4
4 · Athira Pharma, Inc. · Filed Jun 16, 2021
Insider Transaction Report
Form 4
FLUKE JOHN M JR
Director
Transactions
- Other
Common Stock
2021-06-15−3,000→ 3,731 total(indirect: Fluke Capital Management, L.P.) - Other
Common Stock
2021-06-15+1,000→ 144,884 total
Footnotes (4)
- [F1]Fluke Capital Management, L.P. distributed these shares to its partners on a pro rata basis for no consideration (the "Distribution").
- [F2]The Reporting Person disclaims beneficial ownership of the shares of common stock reported herein except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- [F3]The Reporting Person is a director of Fluke Management Corp., which is the managing general partner of Fluke Capital Management, L.P. The Reporting Person is also a partner of Fluke Capital Management, L.P. By virtue of such relationships, Mr. Fluke may be deemed to have voting and investment power with respect to the shares held by Fluke Capital Management, L.P. and as a result may be deemed to have beneficial ownership of such shares.
- [F4]Acquisition by the Reporting Person pursuant to the Distribution.